The unique combination of Malva sylvestris L. flower extract and hyaluronic acid provides advantageous efficacy for treatment of dry eye disease
Planta Medica · 01.03.2026 · 92 (03) · 323
DOI: 10.1055/s-0045-1815198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von J Röhrl und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Dry eye disease (DED) is a multifactorial disease with symptoms such as itching, foreign body sensation, redness and pain [ 1 ]. The hyperosmolar environment due to loss of tear volume triggers the release of pro-inflammatory mediators and oxidative stress due to the release of oxygen radicals [ 2 ]. First line treatment for mild to severe DED is mostly based on eye drops containing hyaluronic acid (HA) [ 3 ]. However, treatment with HA alone neglects oxidative stress. The herbal Malva sylvestris L. flos (MS) extract was investigated in the oxygen radical absorbance capacity (ORAC) assay and the cellular antioxidant assay (CAA). Physicochemical studies with MS and HA were performed to determine surface tension, coefficient of friction and mucoadhesion. An experimental in vitro 3D model of DED using human reconstructed corneal epithelium (HCE) was used to analyse the therapeutic capacity of MS and HA. In both cell-free and cell-based antioxidant assays, MS showed oxygen radical scavenging activity, indicating its antioxidant capacity and cellular uptake. Using HA-containing eye drops plus MS extract, surface tension was significantly reduced compared to a HA-only preparation. Notably, the combination of HA and MS significantly reduced the coefficient of friction compared to single compounds. Additionally, the MS mucilage and HA demonstrated significant mucoadhesion. In the 3D HCE model for dry eye associated ocular surface damage MS and HA showed potent tissue protective effects. These data indicate that the MS flower extract exerts an effective contribution to common HA treatments in DED therapy due to its comprehensive beneficial antioxidant and physicochemical properties. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Röhrl, J., Piqué-Borràs, M., Eiff, M. M., & Künstle, G. (2026). The unique combination of Malva sylvestris L. flower extract and hyaluronic acid provides advantageous efficacy for treatment of dry eye disease. Planta Medica, 92(03), 323. https://doi.org/10.1055/s-0045-1815198
Vancouver
Röhrl J, Piqué-Borràs M, Eiff MM, Künstle G. The unique combination of Malva sylvestris L. flower extract and hyaluronic acid provides advantageous efficacy for treatment of dry eye disease. Planta Medica. 2026;92(03):323. doi:10.1055/s-0045-1815198
BibTeX
@article{Rhrl2026,
author = {Röhrl, J and Piqué-Borràs, M-R and Eiff, M Menett-von and Künstle, G},
title = {The unique combination of Malva sylvestris L. flower extract and hyaluronic acid provides advantageous efficacy for treatment of dry eye disease},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {323},
doi = {10.1055/s-0045-1815198}
}
EUVIMED